drugset / Trial / NCT02357888
Assessment of V0018 2.5 mg Effect on Craving
RandomizedCrossoverQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the reduction of craving and its time course after administration of V0018 2.5 mg compared to placebo in healthy highly dependant smokers.
Timeline
- Start
- 2015-02
- Primary completion
- 2015-05
- Completion
- 2015-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VANILLYL ALCOHOL | Small molecule | 2.5 mg | Other |